# UNIV OF MASSACHUSETTS MED SCH WORCESTER: AAV-mediated gene silencing for the treatment of Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC)

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIV OF MASSACHUSETTS MED SCH WORCESTER |
| Location | WORCESTER, MA |
| Project | AAV-mediated gene silencing for the treatment of Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) |
| Project number | 1R21NS146929-01A1 |
| Mechanism | R21 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $460,625 |
| Awarded | 2026-08-31 |
| Project period | 2026-09-01 to 2028-08-31 |
| UEI | MQE2JHHJW9Q8 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11453305). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.